AstraZeneca shares jump in London after US court victory to protect cholesterol drug patent
AstraZeneca shares jump in London after US court victory to protect cholesterol drug patent LONDON – Shares in AstraZeneca rose sharply in London Wednesday after the drug company won a U.S. court ruling to protect a patent for its blockbuster cholesterol drug, Crestor. Read more on Minneapolis-St. Paul Star Tribune
Merck settles patent dispute on cholesterol drug
Merck settles patent dispute on cholesterol drug Merck & Co. said Monday it settled a patent dispute with Glenmark Pharmaceuticals on the cholesterol drug Zetia, one of its best-selling products. Read more on AP via Yahoo! News